Mereo BioPharma Group plc reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was GBP 7.13 million. Net loss was GBP 11.03 million compared to GBP 19.16 million a year ago.

Basic loss per share from continuing operations was GBP 0.1 compared to GBP 0.15 a year ago. Diluted loss per share from continuing operations was GBP 0.1 compared to GBP 0.15 a year ago.